Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Recruiting · NCT07627815 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Fatigue, Infections, Mental Fatigue, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-06-04 | NCT07627815 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ParagonClinicals Inc. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cardio Health | Mississauga | Canada | 1 |
| Cardio Health | North York | Canada | 1 |
| Cardio Health | London | Canada | 1 |
| Cardio Health | Brampton | Canada | 1 |